Trial Profile
Lorcaserin in Obesity: Identification of CNS Targets Using fMRI
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Mar 2023
Price :
$35
*
At a glance
- Drugs Lorcaserin (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 20 Mar 2023 Planned End Date changed from 1 Dec 2023 to 1 Mar 2024.
- 20 Mar 2023 Planned primary completion date changed from 1 Oct 2023 to 1 Mar 2024.
- 28 Feb 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2023.